A Line in a Tom Stoppard Play Inspired a New Breast Cancer Treatment
In a letter to the Times of London, Dr. Michael Baum tells how a line in Arcadia by Tom Stoppard sparked an idea which resulted in adjuvant systemic chemotherapy, a therapy Baum helped pioneer which greatly increased the survivability of breast cancer.
Sir, In 1993 my wife and I went to see the first production of Arcadia by Tom Stoppard (obituary, Dec 1), and in the interval I experienced a Damascene conversion. As a clinical scientist I was trying to understand the enigma of the behaviour of breast cancer, the assumption being that it grew in a linear trajectory spitting off metastases on its way. In the first act of Arcadia, Thomasina asks her tutor, Septimus: “If there is an equation for a curve like a bell, there must be an equation for one like a bluebell, and if a bluebell, why not a rose?” With that Stoppard explains chaos theory, which better explains the behaviour of breast cancer. At the point of diagnosis, the cancer must have already scattered cancer cells into the circulation that nest latent in distant organs. The consequence of that hypothesis was the birth of “adjuvant systemic chemotherapy”, and rapidly we saw a striking fall of the curve that illustrated patients’ survival.
Stoppard never learnt how many lives he saved by writing Arcadia.
Michael Baum
Professor emeritus of surgery; visiting professor of medical humanities, UCL
Certainly drives home the value of a robust and diverse culture of humanities in contradiction to the current backlash. (via @harrywallop.co.uk)




Comments 1
I am not sure if letters to newspapers are supposed to be fact checked but this is not true:
https://pubmed.ncbi.nlm.nih.gov/2563046/
Hello! In order to comment or fave, you need to be a current kottke.org member. If you'd like to sign up for a membership to support the site and join the conversation, you can explore your options here.
Existing members can sign in here. If you're a former member, you can renew your membership.
Note: If you are a member and tried to log in, it didn't work, and now you're stuck in a neverending login loop of death, try disabling any ad blockers or extensions. Or try logging out and then back in. Still having trouble? Email me!
In order to comment or fave, you need to be a current kottke.org member. Check out your options for renewal.
This is the name that'll be displayed next to comments you make on kottke.org; your email will not be displayed publicly. I'd encourage you to use your real name (or at least your first name and last initial) but you can also pick something that you go by when you participate in communities online. Choose something durable and reasonably unique (not "Me" or "anon"). Please don't change this often. No impersonation.
Note: I'm letting folks change their display names because the membership service that kottke.org uses collects full names and I thought some people might not want their names displayed publicly here. If it gets abused, I might disable this feature.
If you feel like this comment goes against the grain of the community guidelines or is otherwise inappropriate, please let me know and I will take a look at it.
Hello! In order to leave a comment, you need to be a current kottke.org member. If you'd like to sign up for a membership to support the site and join the conversation, you can explore your options here.
Existing members can sign in here. If you're a former member, you can renew your membership.
Note: If you are a member and tried to log in, it didn't work, and now you're stuck in a neverending login loop of death, try disabling any ad blockers or extensions. Or try logging out and then back in. Still having trouble? Email me!